{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:28:18Z","timestamp":1791174498286,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The unique noninvasive MRI technique was used to assess trabecular microarchitecture at multiple skeletal sites in 91 postmenopausal osteoporotic women receiving nasal spray salmon calcitonin (CT-NS) or placebo over 2 years. In the distal radius and lower trochanter of the hip, individuals treated with CT-NS exhibited significant preservation of trabecular bone microarchitecture compared with placebo, where significant deterioration was shown. MRI analyses of os calcis or \u03bcCT\/histomorphometric analyses of bone biopsies did not reveal consistent differences in architecture between CT-NS and placebo.<\/jats:p>\n               <jats:p>Introduction: It is postulated that the reduction in osteoporotic fracture risk in response to certain antiresorptive osteoporosis therapies is caused less by effects on bone quantity than on bone quality (specifically trabecular microarchitecture). To test this hypothesis, the QUEST study was conducted to assess the effects of nasal spray salmon calcitonin (CT-NS) or placebo on parameters of trabecular microarchitecture at multiple skeletal sites using noninvasive MRI technology and iliac crest bone biopsies by \u03bcCT\/histomorphometry.<\/jats:p>\n               <jats:p>Materials and Methods: Ninety-one postmenopausal osteoporotic women were followed for 2 years (n = 46 for CT-NS, n = 45 for placebo); all women received 500 mg calcium daily. MRI measurements at distal radius, hip (T2 relaxation time {T2}), and os calcis (obtained yearly), iliac crest bone biopsies with 2D histomorphometry and 3D \u03bcCT (obtained at study onset and conclusion), DXA-BMD at spine\/hip\/wrist\/os calcis (obtained yearly), and markers of bone turnover (obtained at 2-week to 12-month intervals) were analyzed, with an analysis of covariance model used to assess treatment effect for parameters of interest.<\/jats:p>\n               <jats:p>Results and Conclusions: MRI assessment of trabecular microarchitecture at individual regions of the distal radius revealed significant improvement, or preservation (no significant loss), in the CT-NS-treated group compared with significant deterioration in the placebo control group, as reflected in apparent BV\/TV (p &amp;lt; 0.03), apparent trabecular number (p &amp;lt; 0.01), and apparent trabecular spacing (p &amp;lt; 0.01). Also, at the hip, the CT-NS group exhibited preservation of trabecular microarchitecture at the lower trochanter (p &amp;lt; 0.05) as determined by T2MRI technology. Significant deterioration of trabecular bone architecture was noted in the placebo group at the femoral neck, Ward's triangle, and lower trochanteric sites. Apart from a significant increase in apparent trabecular number in the CT-NS group, significant changes within or between groups were not noted at the os calcis. Combined \u03bcCT\/histomorphometric analysis of iliac crest bone biopsies did not reveal significant differences between treated and placebo groups. In the CT-NS group, regardless of the change in BMD (gain or loss) at the spine, hip, or distal radius, preservation of parameters of trabecular microarchitecture was noted, whereas in the placebo group, regardless of the change in BMD (gain or loss) at the spine, hip, or distal radius, loss or preservation was noted; however, changes in DXA\/BMD (of the spine, hip, wrist, os calcis) between CT-NS and placebo groups were not significant. Serum C-telopeptide (S-CTx), a specific bone resorption marker, was reduced by 22.5% at 24 months (p = 0.056). The results of the QUEST study suggest therapeutic benefit of CT-NS compared with placebo in maintaining trabecular microarchitecture at multiple skeletal sites and support the use of MRI technology for assessment of trabecular microarchitecture in clinical research trials. However, the results also highlight site specific differences in response to antiresorptive therapies and the importance of sufficiently large sampling volumes (areas) to obtain reliable assessment of bone architecture.<\/jats:p>","DOI":"10.1359\/jbmr.050411","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T09:09:23Z","timestamp":1146128963000},"page":"1548-1561","source":"Crossref","is-referenced-by-count":141,"title":["Effects of Salmon Calcitonin on Trabecular Microarchitecture as Determined by Magnetic Resonance Imaging: Results From the QUEST Study"],"prefix":"10.1093","volume":"20","author":[{"suffix":"III","given":"Charles H","family":"Chesnut","sequence":"first","affiliation":[{"name":"Osteoporosis Research Group, Department of Radiology (UWMC-ORG), University of Washington Medical Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmilla","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Magnetic Resonance Science Center, Department of Radiology, University of California at San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Newitt","sequence":"additional","affiliation":[{"name":"Magnetic Resonance Science Center, Department of Radiology, University of California at San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Shields","sequence":"additional","affiliation":[{"name":"Osteoporosis Research Group, Department of Radiology (UWMC-ORG), University of Washington Medical Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Van Pelt","sequence":"additional","affiliation":[{"name":"Osteoporosis Research Group, Department of Radiology (UWMC-ORG), University of Washington Medical Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Laschansky","sequence":"additional","affiliation":[{"name":"Osteoporosis Research Group, Department of Radiology (UWMC-ORG), University of Washington Medical Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moise","family":"Azria","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals, Basle, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Kriegman","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals, East Hanover, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin","family":"Olson","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals, Basle, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik F","family":"Eriksen","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals, Basle, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mindeholm","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals, Basle, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024013019252222900_bib1","author":"National Institutes of Health (NIH) Consensus Development Panel","year":"2000"},{"key":"2024013019252222900_bib2","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1359\/jbmr.2001.16.12.2163","article-title":"Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture (Perspective)","volume":"16","author":"Chesnut","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(00)00301-X","article-title":"How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?","volume":"27","author":"Delmas","year":"2000","journal-title":"Bone"},{"key":"2024013019252222900_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1359\/jbmr.2002.17.1.11","article-title":"Bone turnover matters: The raloxofene paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density","volume":"17","author":"Riggs","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The Prevent Recurrence of Osteoporotic Fracture study","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"key":"2024013019252222900_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"2024013019252222900_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1359\/jbmr.2002.17.1.1","article-title":"Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy","volume":"17","author":"Sarkar","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","article-title":"Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with anti-resorptive drugs","volume":"112","author":"Cummings","year":"2002","journal-title":"Am J Med"},{"key":"2024013019252222900_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1359\/jbmr.1999.14.7.1167","article-title":"Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine, femur, iliac crest and calcaneus","volume":"14","author":"Hildebrand","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s001980200027","article-title":"In vivo assessment of architecture and micro-finite element analysis derived indices of mechanical properties of trabecular bone in the radius","volume":"13","author":"Newitt","year":"2002","journal-title":"Osteoporos Int"},{"key":"2024013019252222900_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mrm.1910340321","article-title":"Phased array detectors and an automated intensity-correction algorithm for high-resolution MR imaging of the human brain","volume":"34","author":"Wald","year":"1995","journal-title":"Magn Reson Med"},{"key":"2024013019252222900_bib13","author":"Newitt","year":"2000"},{"key":"2024013019252222900_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1359\/jbmr.1997.12.1.111","article-title":"Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: In vivo studies in the distal radius using high resolution magnetic resonance imaging","volume":"12","author":"Majumdar","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S8756-3282(98)00030-1","article-title":"High-resolution magnetic resonance imaging: Three-dimensional trabecular bone architecture and biomechanical properties","volume":"22","author":"Majumdar","year":"1998","journal-title":"Bone"},{"key":"2024013019252222900_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2818.1997.1340694.x","article-title":"A new method for the model independent assessment of thickness in three-dimensional images","volume":"185","author":"Hildebrand","year":"1997","journal-title":"J Microsc"},{"key":"2024013019252222900_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s001980200027","article-title":"Processing and analysis of in vivo high-resolution MR images of trabecular bone for longitudinal studies: Reproducibility of structural measures and micro-finite element analysis derived mechanical properties","volume":"13","author":"Newitt","year":"2002","journal-title":"Osteoporos Int"},{"key":"2024013019252222900_bib18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/edrv-7-4-379","article-title":"Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease","volume":"7","author":"Eriksen","year":"1986","journal-title":"Endocr Rev"},{"key":"2024013019252222900_bib19","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","article-title":"Recombinant human parathyroid hormone (1-34) (Teriparatide) improves both cortical and cancellous bone structure","volume":"18","author":"Jiang","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib20","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/B978-012098652-1.50195-5","volume-title":"Principles of Bone Biology","author":"Jiang","year":"2002","edition":"2nd ed."},{"key":"2024013019252222900_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s001980050221","article-title":"Trabecular bone architecture in the distal radius using magnetic resonance imaging in subjects with fractures of the proximal femur","volume":"10","author":"Majumdar","year":"1999","journal-title":"Osteoporos Int"},{"key":"2024013019252222900_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S8756-3282(96)00227-X","article-title":"The effects of long-term hormone replacement therapy on bone remodeling in postmenopausal women","volume":"19","author":"Vedi","year":"1996","journal-title":"Bone"},{"key":"2024013019252222900_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/8756-3282(89)90126-9","article-title":"A randomized study on the effects of estrogen\/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis","volume":"10","author":"Steiniche","year":"1989","journal-title":"Bone"},{"key":"2024013019252222900_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00223-002-2104-4","article-title":"Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography","volume":"73","author":"Dufresne","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"2024013019252222900_bib25","first-page":"S2","article-title":"Alendronate increases trabecular bone connectivity in elderly osteoporotic women","volume":"18","author":"Masarachia","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib26","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI119668","article-title":"Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis","volume":"100","author":"Chavassieux","year":"1997","journal-title":"J Clin Invest"},{"key":"2024013019252222900_bib27","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","article-title":"Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study","volume":"16","author":"Dempster","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib28","first-page":"63","article-title":"An evaluation of the quantitative parameters applied in bone histology","volume":"86","author":"Melson","year":"1978","journal-title":"Acta Pathol Microbiol Scand"},{"key":"2024013019252222900_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S8756-3282(99)00098-8","article-title":"The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone","volume":"25","author":"Ulrich","year":"1999","journal-title":"Bone"},{"key":"2024013019252222900_bib30","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1359\/jbmr.2001.16.8.1511","article-title":"Trabecular structure assessment in lumbar vertebrae specimens using quantitative magnetic resonance imaging and relationship to mechanical competence","volume":"16","author":"Beuf","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib31","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1359\/jbmr.2001.16.8.1520","article-title":"Digital topological analysis of in vivo magnetic resonance microimages of trabecular bone reveals structural implications of osteoporosis","volume":"16","author":"Wehrli","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1359\/jbmr.1998.13.1.122","article-title":"A comparative study of trabecular bone properties in the spine and femur using high resolution MRI and CT","volume":"13","author":"Link","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib33","first-page":"S2","article-title":"Longitudinal changes in trabecular bone architecture detected by micro-MRI based virtual bone biopsy","volume":"18","author":"Wehrli","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib34","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/8756-3282(92)90196-4","article-title":"Implications of architecture for the pathogenesis and prevention of vertebral fracture","volume":"13","author":"Parfitt","year":"1992","journal-title":"Bone"},{"key":"2024013019252222900_bib35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF02554913","article-title":"The role of three-dimensional trasbecular microstructure in the pathogenesis of vertebral compression fractures","volume":"37","author":"Kleerekoper","year":"1985","journal-title":"Calcif Tissue Int"},{"key":"2024013019252222900_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1359\/jbmr.2000.15.1.32","article-title":"Variations in three-dimensional cancellous bone architecture of the proximal femur in female hip fractures and in controls","volume":"15","author":"Ciarelli","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1359\/jbmr.2000.15.1.13","article-title":"Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis","volume":"15","author":"Legrand","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1359\/JBMR.041008","article-title":"Femoral neck trabecular microstructure in ovariectomized ewes treated with calcitonin: MRI microscopic evaluation","volume":"20","author":"Jiang","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib39","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"2024013019252222900_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1359\/jbmr.1997.12.1.111","article-title":"Correlations of trabecular bone structure with age, bone mineral density, and osteoporotic status: In vivo studies in the distal radius using high resolution magnetic resonance imaging","volume":"12","author":"Majumdar","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S8756-3282(02)00686-5","article-title":"Zone-dependent changes in human vertebral trabecular bone: Clinical implications","volume":"30","author":"Thomsen","year":"2002","journal-title":"Bone"},{"key":"2024013019252222900_bib42","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S8756-3282(02)00736-6","article-title":"Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images","volume":"30","author":"Pistoia","year":"2002","journal-title":"Bone"},{"key":"2024013019252222900_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00223-004-0036-x","article-title":"Acute effects of calcitonin nasal spray on serum serum C-telopeptide of type 1 collagen (CTx) levels in elderly osteopenic women with increased bone turnover","volume":"75","author":"Srivastava","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"2024013019252222900_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0009-8981(01)00731-8","article-title":"Plasma type 1 collagen cross-linked C-telopeptide: A sensitive marker of acute effects of salmon calcitonin on bone resorption","volume":"316","author":"Zikan","year":"2002","journal-title":"Clin Chim Acta"},{"key":"2024013019252222900_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF00297179","article-title":"Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: A dose-response study","volume":"55","author":"Overgaard","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"2024013019252222900_bib46","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1359\/JBMR.040715","article-title":"Safety and efficacy of a novel Eligen technology-based oral formulation of salmon calcitonin in healthy postmenopausal women: Acute and three-month effects on biomarkers of bone turnover","volume":"19","author":"Tanko","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024013019252222900_bib47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/endo-123-1-159","article-title":"The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation","volume":"123","author":"Farley","year":"1988","journal-title":"Endocrinology"},{"key":"2024013019252222900_bib48","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1248\/bpb.23.946","article-title":"Bone-anabolic effect of salmon calcitonin on glucocorticoid-induced osteopenia in rats","volume":"23","author":"Furuichi","year":"2000","journal-title":"Biol Pharm Bull"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2FJBMR.050411","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/20\/9\/1548\/56476613\/5650200907.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/20\/9\/1548\/56476613\/5650200907.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:09:27Z","timestamp":1710342567000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/20\/9\/1548-1561\/7593000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.050411","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,9,1]]},"published":{"date-parts":[[2005,9,1]]}}}